Biden reportedly set to invoke Defense Production Act to speed up COVID-19 vaccine production


"You will see" President-elect Joe Biden invoke the Defense Production Act after he takes office in January, Dr. Celine Gounder, a member of Biden's COVID-19 advisory board, said during an interview on CNBC's Squawk Box on Monday. "The idea there is to make sure the personal protective equipment, the test capacity, and the raw materials for the vaccines are produced in adequate supply," she added.
The wartime production law allows the president to order companies to prioritize manufacturing that is related to national security. President Trump invoked the act earlier this year after some hesitation to increase the supply of ventilators.
Biden's team has reportedly been stewing over whether to invoke the law, and Gounder's statement indicates they are leaning that way. It's unclear exactly how Biden would use the law, and questions of equity remain, CNBC notes. For example, the U.S. government reportedly agreed to invoke the DPA as part of its deal in securing an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine. In that scenario, the law would "help Pfizer get better access to around nine specialized products it needs to make the vaccine," so there is concern Pfizer would be unfairly favored over other manufacturers. As things stand, however, only Pfizer and Moderna have vaccines approved for emergency use. Read more at CNBC.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Palestine Action: protesters or terrorists?
Talking Point Damaging RAF equipment at Brize Norton blurs line between activism and sabotage, but proscription is a drastic step
-
Trump's strikes on Iran: a 'spectacular success'?
In Depth Military humiliations 'expose the brittleness' of Tehran's ageing regime, but risk reinforcing its commitment to its nuclear program
-
5 expletive-laden cartoons about bad language
Cartoons Artists take on Trump's quest for a Nobel Peace Prize, cursing at the dinner table, and more
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia